Literature DB >> 15147736

Lung fibroblast clones from normal and fibrotic subjects differ in hyaluronan and decorin production and rate of proliferation.

Gunilla Westergren-Thorsson1, Patricia Sime, Manel Jordana, Jack Gauldie, Bengt Särnstrand, Anders Malmström.   

Abstract

Development of fibrosis involves an increase in the deposition of connective tissue components including collagens, fibronectin and proteoglycans. One hypothesis to account for matrix deposition in fibrosis is that fibroblast with differing matrix producing capacity are involved in the fibrotic process. To test this hypothesis, primary fibroblast cultures and clones derived from these primary lines were established from the lung tissue of control patients and patients with pulmonary fibrosis. The primary lines and derived clones were studied in relation to their capacity to proliferate and to produce proteoglycans and hyaluronan. Primary fibroblast cultures and clones from normal subjects and patients with lung fibrosis differed considerably, with up to 13-fold difference, in both hyaluronan and proteoglycan production. The major proteoglycan produced was decorin in both controls and cultures from fibrotic patients, while cultures from patients with lung fibrosis had a higher expression of mRNA for both collagen and decorin. Clones derived from a primary line from a fibrotic patient secreted 3-fold greater amounts of decorin than those from a control subject. Furthermore, a negative correlation between proliferation and synthesis of decorin was noted. We suggest that different fibroblast clones accumulate in the lung, and that specific cell populations of high decorin producing fibroblasts may exist which are crucial in the pathogenesis of fibrosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15147736     DOI: 10.1016/j.biocel.2004.01.009

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  12 in total

1.  Hyaluronan Controls the Deposition of Fibronectin and Collagen and Modulates TGF-β1 Induction of Lung Myofibroblasts.

Authors:  Stephen P Evanko; Susan Potter-Perigo; Loreen J Petty; Gail A Workman; Thomas N Wight
Journal:  Matrix Biol       Date:  2014-12-27       Impact factor: 11.583

Review 2.  Hyaluronan as an immune regulator in human diseases.

Authors:  Dianhua Jiang; Jiurong Liang; Paul W Noble
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

3.  Altered fibroblast proteoglycan production in COPD.

Authors:  Oskar Hallgren; Kristian Nihlberg; Magnus Dahlbäck; Leif Bjermer; Leif T Eriksson; Jonas S Erjefält; Claes-Göran Löfdahl; Gunilla Westergren-Thorsson
Journal:  Respir Res       Date:  2010-05-11

Review 4.  Always cleave up your mess: targeting collagen degradation to treat tissue fibrosis.

Authors:  William McKleroy; Ting-Hein Lee; Kamran Atabai
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-04-05       Impact factor: 5.464

Review 5.  Hyaluronan as a therapeutic target in human diseases.

Authors:  Jiurong Liang; Dianhua Jiang; Paul W Noble
Journal:  Adv Drug Deliv Rev       Date:  2015-11-02       Impact factor: 15.470

Review 6.  Pulmonary fibrosis: patterns and perpetrators.

Authors:  Paul W Noble; Christina E Barkauskas; Dianhua Jiang
Journal:  J Clin Invest       Date:  2012-08-01       Impact factor: 14.808

7.  Functional and phenotypical comparison of myofibroblasts derived from biopsies and bronchoalveolar lavage in mild asthma and scleroderma.

Authors:  Kristoffer Larsen; Johan Malmström; Marie Wildt; Camilla Dahlqvist; Lennart Hansson; György Marko-Varga; Leif Bjermer; Agneta Scheja; Gunilla Westergren-Thorsson
Journal:  Respir Res       Date:  2006-01-23

8.  Lysyl oxidases regulate fibrillar collagen remodelling in idiopathic pulmonary fibrosis.

Authors:  Gavin Tjin; Eric S White; Alen Faiz; Delphine Sicard; Daniel J Tschumperlin; Annabelle Mahar; Eleanor P W Kable; Janette K Burgess
Journal:  Dis Model Mech       Date:  2017-11-01       Impact factor: 5.758

Review 9.  The extracellular matrix - the under-recognized element in lung disease?

Authors:  Janette K Burgess; Thais Mauad; Gavin Tjin; Jenny C Karlsson; Gunilla Westergren-Thorsson
Journal:  J Pathol       Date:  2016-10-28       Impact factor: 7.996

10.  Pulmonary fibrosis in vivo displays increased p21 expression reduced by 5-HT2B receptor antagonists in vitro - a potential pathway affecting proliferation.

Authors:  Anna Löfdahl; Kristina Rydell-Törmänen; Anna-Karin Larsson-Callerfelt; Christina Wenglén; Gunilla Westergren-Thorsson
Journal:  Sci Rep       Date:  2018-01-31       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.